Progyny, Inc.
PGNY
$22.30
$0.351.60%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.21B | 1.17B | 1.14B | 1.13B | 1.11B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.21B | 1.17B | 1.14B | 1.13B | 1.11B |
| Cost of Revenue | 946.43M | 913.86M | 891.91M | 882.79M | 865.72M |
| Gross Profit | 266.75M | 253.36M | 246.83M | 250.21M | 242.57M |
| SG&A Expenses | 193.65M | 185.91M | 181.36M | 179.01M | 176.87M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.14B | 1.10B | 1.07B | 1.06B | 1.04B |
| Operating Income | 73.10M | 67.46M | 65.47M | 71.20M | 65.70M |
| Income Before Tax | 87.22M | 83.20M | 81.81M | 84.78M | 76.88M |
| Income Tax Expenses | 34.73M | 28.87M | 24.53M | 22.02M | 15.62M |
| Earnings from Continuing Operations | 52.50 | 54.34 | 57.27 | 62.75 | 61.26 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 52.50M | 54.34M | 57.27M | 62.75M | 61.26M |
| EBIT | 73.10M | 67.46M | 65.47M | 71.20M | 65.70M |
| EBITDA | 76.67M | 70.63M | 68.41M | 73.88M | 68.15M |
| EPS Basic | 0.59 | 0.59 | 0.61 | 0.66 | 0.64 |
| Normalized Basic EPS | 0.59 | 0.52 | 0.50 | 0.51 | 0.47 |
| EPS Diluted | 0.57 | 0.57 | 0.59 | 0.64 | 0.62 |
| Normalized Diluted EPS | 0.57 | 0.50 | 0.48 | 0.49 | 0.45 |
| Average Basic Shares Outstanding | 355.24M | 366.23M | 376.40M | 381.84M | 382.71M |
| Average Diluted Shares Outstanding | 369.88M | 381.63M | 393.46M | 400.52M | 403.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |